New Needle-Free treatment could replace surgery for adrenal tumors
NCT ID NCT05368090
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new, less invasive procedure called EUS-RFA to standard surgery for treating left-sided adrenal tumors that cause high blood pressure and other hormone-related issues. About 60 participants will receive the new procedure, which uses a thin tube inserted through the mouth to deliver heat and destroy the tumor. Researchers will check if it controls hormone levels as well as surgery, with fewer side effects and a shorter hospital stay.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiofrequency ablation (RFA) delivered via endoscopic ultrasound
What this could lead to
If successful, this could offer a less invasive alternative to surgery for controlling hormone overproduction in primary aldosteronism, reducing recovery time and complications.
What could go wrong
This is an early-stage study with only 60 participants, so results may not apply broadly. The procedure carries risks like bleeding or infection, and it may not control hormone levels as effectively as surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Haukeland University Hospital
RECRUITINGBergen, 5021, Norway
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••